IL2 and neuroblastoma: The combination of IL-2, IL-12, and IL-18 also resulted in potent antitumor activity against different cell lines like Ewing sarcoma (A673), rhabdomyosarcoma (RH30), and neuroblastoma (SH-SY5Y) [150].